Omar Manejwala

Chief Medical Officer

Omar is one of the world’s leading experts on behavior change. He is keen on behavior change in chronic disease, and his career is characterized by developing, piloting, and commercializing scalable solutions that drive durable behavior change. As Chief Medical Officer at Dario, Omar is responsible for its clinical solutions and provides visible external and internal leadership and develops and maintains C-level health plan relationships. He conducts clinical research, vets clinical partnerships, and sets clinical product and sales strategies to drive clinical and financial outcomes. Previous roles include Chief Medical Officer of Catasys (now OnTrak, Nasdaq: OTRK), where he led Product from zero to pilots and then to commercial scale, securing contracts for the OnTrak program with most of the largest health plans in the US and several regional plans and offering services in 28 states. He has developed and scaled solutions for commercial, exchange, managed Medicare Advantage, and managed Medicaid adult populations, as well as employer markets. Innovative products and clinical protocols he has developed are helping thousands of people get the care they desperately need to improve their health and reduce their overall costs. These solutions and partnerships are directly responsible for Catasys/OnTrak’s growth from zero to an approximately $400m valuation. Prior to Catasys/OnTrak, he held various leadership roles, most recently as Medical Director at Hazelden. He has an MBA from the University of Virginia’s Darden School of Business, an M.D. from the University of Maryland School of Medicine and served as Executive Chief Resident in Psychiatry at Duke University.

Talks About
#healthcare #mentalhealth #digitalhealth #chronicconditions #healthcareinnovation

Preferred Locations
#UnitedStates